Physician profile
Rohit T Repala
NPI 1457617169
$5,447.28
in general payments reported to CMS, 2019-2025
10 companies · $900 in 2025
The $900 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,600 · 2020: $204 · 2023: $1,304 · 2024: $439 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,518 · Food and Beverage: $619 · Long Term Medical Supply Or Device Loan: $405 · Education: $84.90 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,517.92 |
| Food and Beverage | $619.40 |
| Long Term Medical Supply Or Device Loan | $404.85 |
| Education | $84.90 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,783.64 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $853.71 | 2025 | Gore Synecor Preperitoneal Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Integra Lifesciences Corporation | $420.00 | 2024 | Acell, Integra, Integra Dermal Regeneration Template |
| Acell, INC. | $204.49 | 2019-2020 | |
| Abbvie INC. | $59.37 | 2020 | |
| Ethicon US, LLC | $40.18 | 2023 | Enseal, Monocryl, Ethicon |
| Allergan, INC. | $24.64 | 2020 | |
| Janssen Biotech, INC. | $22.66 | 2025 | Erleada |
| Boston Scientific Corporation | $19.53 | 2025 | Spyglass Discover |
| Axonics, INC. | $19.06 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Repala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.